Weekly CFO Buys Highlight

Recent buys from company CFOs

Author's Avatar
Jul 02, 2019
Article's Main Image

According to GuruFocus Insider Data, the recent CFO buys were from: Exela Technologies Inc. (XELA, Financial), Grocery Outlet Holding Corp (GO, Financial) and Biohaven Pharmaceutical Holding Co Ltd (BHVN, Financial).

Exela Technologies Inc. (XELA, Financial): CFO James Reynolds bought 247,630 shares

CFO James Reynolds bought 247,630 shares for $1.65 per share on June 25. Since then, the stock price has increased by 32.73%. Exela Technologies Inc. has a market cap of $328.813 million, and its shares were traded around $2.19. The company has a price-sales ratio of 0.21.

The company announced first-quarter revenue of $403.77 million and gross profit of $96.88 million, while the net loss was $29.91 million. The 2018 total revenue was $1.59 billion, a 38% increase from 2017. The gross profit was $376.35 million, a 16% increase from the year prior. The net loss was $162.52 million.

CEO Ronald Clark Cogburn bought 13,757 shares for $1.65 per share on June 25. Since then, the stock price has increased by 32.73%. Director, 10% Owner Par Chadha sold 6,012,108 shares for $1.65 per share on June 25. Since then, the stock price has increased by 32.73%. Director, 10% Owner 2 LLC Ex-sigma sold 13,234,848 shares for $1.65 per share on June 25. Since then, the stock price has increased by 32.73%.

Grocery Outlet Holding Corp. (GO, Financial): CFO Charles Bracher bought 2,610 shares

CFO Charles Bracher bought 2,610 shares for $22 per share on June 24. Since then, the stock price has increased by 49.45%. Grocery Outlet Holding Corp has a market cap of $3.47 billion, and its shares were traded around $32.88. The company has a price-earnings ratio of 234.84.

The company announced first-quarter revenue of $606.27 million and gross profit of $187.02 million, while the net income was $3.77 million. The 2018 total revenue was $2.29 billion, a 10% increase from 2017. The gross profit was $695.40 million, a 10% increase from the year prior. The net income was $15.87 million.

CEO Eric J. Lindberg Jr. bought 920 shares for $22 per share on June 24. Since then, the stock price has increased by 49.45%. President Robert Joseph Sheedy Jr. bought 10,000 shares for $22 per share on June 24. Since then, the stock price has increased by 49.45%. Director Jeffrey York bought 25,000 shares for $22 per share on June 24. Since then, the stock price has increased by 49.45%.

Biohaven Pharmaceutical Holding Co. Ltd. (BHVN, Financial): CFO James Engelhart bought 2,500 shares

CFO James Engelhart bought 2,500 shares for $43.05 per share on June 27. Since then, the stock price has increased by 1.72%. Biohaven Pharmaceutical Holding Co. Ltd. has a market cap of $2.26 billion and its shares were traded around $43.79.

The company announced first-quarter gross loss of $33.29 million, while the net loss was $62.30 million. The 2018 gross loss was $108.46 million, a 49% decrease from the year prior. The net loss was $240.92 million.

CEO Vlad Coric bought 5,000 shares for $40.22 per share on June 26. Since then, the stock price has increased by 8.88%. Chief Medical Officer Robert Berman bought 2,500 shares for $42.3 per share on June 27. Since then, the stock price has increased by 3.52%. Director John W. Childs bought 10,000 shares for $40.37 per share on June 26. Since then, the stock price has increased by 8.47%.

Disclosure: none.Â

Read more here:Â

Weekly CFO Sells HighlightÂ

Weekly CFO Buys HighlightÂ

Weekly CFO Sells HighlightÂ

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.